In order to explore the potential of this PD-L1 dual-anchor coupling approach for the treatment of other autoimmune diseases, we further conducted a proof-of-concept evaluation in rheumatoid arthritis (RA). This evidence concerns the gene CD274 and rheumatoid arthritis.